Table of contents


On 22 February 2018, orphan designation (EU/3/18/1976) was granted by the European Commission to Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Germany, for allogeneic CD4+ and CD25+ T lymphocytes ex vivo incubated with GP120 for the treatment in haematopoietic stem cell transplantation.

Key facts

Active substance
Allogeneic CD4+ and CD25+ T lymphocytes ex vivo incubated with GP120
Disease / condition
Treatment in haematopoietic stem cell transplantation
Date of decision
Orphan decision number

Sponsor's contact details

Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Department for Dermatology
Langenbeckstr. 1
55131 Mainz
Tel. +49 173 65 52 473

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating